spacer
spacer

PDBsum entry 3mj5

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Viral protein PDB id
3mj5

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
312 a.a. *
262 a.a. *
Ligands
GRM ×2
Metals
_ZN ×2
Waters ×119
* Residue conservation analysis
PDB id:
3mj5
Name: Viral protein
Title: Severe acute respiratory syndrome-coronavirus papain-like protease inhibitors: design, synthesis, protein-ligand x-ray structure and biological evaluation
Structure: Replicase polyprotein 1a. Chain: a, b. Fragment: sars polyprotein residues 1544-1855. Synonym: pp1a, orf1a polyprotein, non-structural protein 1, nsp1, leader protein, non-structural protein 2, nsp2, p65 homolog, non- structural protein 3, nsp3, papain-like proteinase, pl-pro, pl2-pro, non-structural protein 4, nsp4, 3c-like proteinase, 3cl-pro, 3clp, nsp5, non-structural protein 6, nsp6, non-structural protein 7, nsp7, non-structural protein 8, nsp8, non-structural protein 9, nsp9, non-
Source: Sars coronavirus. Sars-cov. Organism_taxid: 227859. Strain: urbani. Gene: 1a, orf1 (nsp3) residues 1544-1855. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.63Å     R-factor:   0.211     R-free:   0.248
Authors: A.D.Mesecar,K.M.Ratia,S.D.Pegan
Key ref: A.K.Ghosh et al. (2010). Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation. J Med Chem, 53, 4968-4979. PubMed id: 20527968
Date:
12-Apr-10     Release date:   30-Jun-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P0C6U8  (R1A_CVHSA) -  Replicase polyprotein 1a from Severe acute respiratory syndrome coronavirus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
4382 a.a.
312 a.a.
Protein chain
Pfam   ArchSchema ?
P0C6U8  (R1A_CVHSA) -  Replicase polyprotein 1a from Severe acute respiratory syndrome coronavirus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
4382 a.a.
262 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.7.50  - mRNA guanylyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
5'-end diphospho-ribonucleoside in mRNA
+ GTP
+ H(+)
= 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
+ diphosphate
   Enzyme class 2: Chains A, B: E.C.3.4.19.12  - ubiquitinyl hydrolase 1.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
   Enzyme class 3: Chains A, B: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 4: Chains A, B: E.C.3.4.22.69  - Sars coronavirus main proteinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
J Med Chem 53:4968-4979 (2010)
PubMed id: 20527968  
 
 
Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation.
A.K.Ghosh, J.Takayama, K.V.Rao, K.Ratia, R.Chaudhuri, D.C.Mulhearn, H.Lee, D.B.Nichols, S.Baliji, S.C.Baker, M.E.Johnson, A.D.Mesecar.
 
  ABSTRACT  
 
The design, synthesis, X-ray crystal structure, molecular modeling, and biological evaluation of a series of new generation SARS-CoV PLpro inhibitors are described. A new lead compound 3 (6577871) was identified via high-throughput screening of a diverse chemical library. Subsequently, we carried out lead optimization and structure-activity studies to provide a series of improved inhibitors that show potent PLpro inhibition and antiviral activity against SARS-CoV infected Vero E6 cells. Interestingly, the (S)-Me inhibitor 15 h (enzyme IC(50) = 0.56 microM; antiviral EC(50) = 9.1 microM) and the corresponding (R)-Me 15 g (IC(50) = 0.32 microM; antiviral EC(50) = 9.1 microM) are the most potent compounds in this series, with nearly equivalent enzymatic inhibition and antiviral activity. A protein-ligand X-ray structure of 15 g-bound SARS-CoV PLpro and a corresponding model of 15 h docked to PLpro provide intriguing molecular insight into the ligand-binding site interactions.
 

 

spacer

spacer